Cloxacillin Injectable Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV, IM)
Available Strengths: 1 g, 2 g
Reference Brands: Cloxacillin, Orbenin(US)
Category:
Antibiotics
Cloxacillin injectable inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis. It provides rapid, effective treatment for penicillinase-producing staphylococcal infections. Benefits include high efficacy, good tissue penetration, and suitability for severe infections in hospital settings when administered properly under medical supervision.
Cloxacillin Injectable is available in Injectable (IV, IM)
and strengths such as 1 g, 2 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cloxacillin Injectable is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cloxacillin Injectable can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cloxacillin injectable is approved in the EU and US for treating severe penicillinase-producing staphylococcal infections. In the EU, brands like Orbenin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with strict regulation for proper use. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for cloxacillin injections, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing